Identification of Natural Products Inhibiting SARS-CoV-2 by Targeting Viral Proteases: A Combined in Silico and in Vitro Approach
- PMID: 36651644
- PMCID: PMC9885530
- DOI: 10.1021/acs.jnatprod.2c00843
Identification of Natural Products Inhibiting SARS-CoV-2 by Targeting Viral Proteases: A Combined in Silico and in Vitro Approach
Abstract
In this study, an integrated in silico-in vitro approach was employed to discover natural products (NPs) active against SARS-CoV-2. The two SARS-CoV-2 viral proteases, i.e., main protease (Mpro) and papain-like protease (PLpro), were selected as targets for the in silico study. Virtual hits were obtained by docking more than 140,000 NPs and NP derivatives available in-house and from commercial sources, and 38 virtual hits were experimentally validated in vitro using two enzyme-based assays. Five inhibited the enzyme activity of SARS-CoV-2 Mpro by more than 60% at a concentration of 20 μM, and four of them with high potency (IC50 < 10 μM). These hit compounds were further evaluated for their antiviral activity against SARS-CoV-2 in Calu-3 cells. The results from the cell-based assay revealed three mulberry Diels-Alder-type adducts (MDAAs) from Morus alba with pronounced anti-SARS-CoV-2 activities. Sanggenons C (12), O (13), and G (15) showed IC50 values of 4.6, 8.0, and 7.6 μM and selectivity index values of 5.1, 3.1 and 6.5, respectively. The docking poses of MDAAs in SARS-CoV-2 Mpro proposed a butterfly-shaped binding conformation, which was supported by the results of saturation transfer difference NMR experiments and competitive 1H relaxation dispersion NMR spectroscopy.
Conflict of interest statement
The authors declare no competing financial interest.
Figures






Similar articles
-
Compounds derived from Humulus lupulus inhibit SARS-CoV-2 papain-like protease and virus replication.Phytomedicine. 2024 Jan;123:155176. doi: 10.1016/j.phymed.2023.155176. Epub 2023 Oct 30. Phytomedicine. 2024. PMID: 37976697
-
In Silico Analysis of the Antidepressant Fluoxetine and Related Drugs at SARS-CoV-2 Main Protease (Mpro) and Papain-like Protease (PLpro).Curr Drug Discov Technol. 2023;20(2):e101022209771. doi: 10.2174/1570163819666221010115118. Curr Drug Discov Technol. 2023. PMID: 36221883
-
Identification of Aloe-derived natural products as prospective lead scaffolds for SARS-CoV-2 main protease (Mpro) inhibitors.Bioorg Med Chem Lett. 2022 Jun 15;66:128732. doi: 10.1016/j.bmcl.2022.128732. Epub 2022 Apr 12. Bioorg Med Chem Lett. 2022. PMID: 35427739 Free PMC article.
-
Ebselen derivatives inhibit SARS-CoV-2 replication by inhibition of its essential proteins: PLpro and Mpro proteases, and nsp14 guanine N7-methyltransferase.Sci Rep. 2023 Jun 6;13(1):9161. doi: 10.1038/s41598-023-35907-w. Sci Rep. 2023. PMID: 37280236 Free PMC article.
-
Therapeutic Intervention of COVID-19 by Natural Products: A Population-Specific Survey Directed Approach.Molecules. 2021 Feb 23;26(4):1191. doi: 10.3390/molecules26041191. Molecules. 2021. PMID: 33672163 Free PMC article. Review.
Cited by
-
Discovery of anti-SARS-CoV-2 secondary metabolites from the heartwood of Pterocarpus santalinus using multi-informative molecular networking.Front Mol Biosci. 2023 Jun 6;10:1202394. doi: 10.3389/fmolb.2023.1202394. eCollection 2023. Front Mol Biosci. 2023. PMID: 37347040 Free PMC article.
-
Kaurenoic acid is a potent inhibitor of SARS-CoV-2 RNA synthesis, virion assembly, and release in vitro.Front Microbiol. 2025 May 9;16:1540934. doi: 10.3389/fmicb.2025.1540934. eCollection 2025. Front Microbiol. 2025. PMID: 40415937 Free PMC article.
-
Protease inhibitors from Theobroma cacao impair SARS-CoV-2 replication in vitro.Heliyon. 2023 May;9(5):e15860. doi: 10.1016/j.heliyon.2023.e15860. Epub 2023 May 3. Heliyon. 2023. PMID: 37153407 Free PMC article.
-
Progress in Research on Inhibitors Targeting SARS-CoV-2 Main Protease (Mpro).ACS Omega. 2024 Aug 2;9(32):34196-34219. doi: 10.1021/acsomega.4c03023. eCollection 2024 Aug 13. ACS Omega. 2024. PMID: 39157135 Free PMC article. Review.
-
Biopharmaceutical profiling of anti-infective sanggenons from Morus alba root bark for inhalation administration.Int J Pharm X. 2024 Aug 5;8:100272. doi: 10.1016/j.ijpx.2024.100272. eCollection 2024 Dec. Int J Pharm X. 2024. PMID: 39252692 Free PMC article.
References
-
- World Health Organisation . WHO Coronavirus (COVID-19) Dashboard https://covid19.who.int/ (accessed August 18, 2022).
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Chemical Information
Medical
Miscellaneous